AstraZeneca's (AZN) Rare Blood Disorder Drug Gets FDA Nod

AstraZeneca AZN announced that the FDA had approved Voydeya (danicopan) for treating paroxysmal nocturnal hemoglobinuria (PNH), a rare and chronic blood disorder. https://www.nasdaq.com/articles/astrazenecas-azn-rare-blood-disorder-drug-gets-fda-nod